According to the information available, Cosentyx (secukinumab) is a medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a type of drug known as a monoclonal antibody, which works by targeting and blocking a specific protein in the body that contributes to inflammation [1].

Regarding live vaccines, the manufacturer's prescribing information for Cosentyx states that "live vaccines should be avoided in patients treated with SECUKINUMAB" [2]. This recommendation is due to the potential risk of infection and reduced effectiveness of live vaccines in individuals receiving immunosuppressive therapy, such as Cosentyx [3].

Therefore, based on the available information, it is not recommended to receive live vaccines during Cosentyx therapy. However, it is crucial to consult with a healthcare professional for personalized medical advice, as they can provide guidance based on individual circumstances and health history.

Sources:

1. Cosentyx (secukinumab) [Internet]. Drugs.com. [cited 2023 Mar 15]. Available from: <https://www.drugs.com/cosentyx.html>.
2. SECUKINUMAB [Internet]. Lexicomp.com. [cited 2023 Mar 15]. Available from: <https://www.lexicomp.com/lexicomp/lite/action/doc/retrieve/docid/patch_f/733282>.
3. Vaccines and immunizations during treatment with biologic agents [Internet]. American College of Rheumatology. [cited 2023 Mar 15]. Available from: <https://www.rheumatology.org/I-Am-A/Patient-Caregiver/Treatments/Vaccines-and-Immunizations-During-Treatment-with-Biologic-Agents>.